CYCLERION THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
CYCLERION THERAPEUTICS, INC. (CYCN) reported Basic Shares Outstanding (Weighted Average) of 4.25 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 4.25M shares, a 38.42% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.21M shares, a 64.51% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 3.81M shares, a 49.92% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.23M shares, a 27.67% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 2.34M shares, a 7.59% increase from fiscal 2022.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 2.17M shares, a 94.45% decline from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 39.14M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.25M shares 10-Q · filed 2026-08-04 | 4.23M shares 10-Q · filed 2026-08-04 | 4.09M shares derived: average of 3 quarters · filed 2026-08-04 | 3.87M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | 4.21M shares S-4/A · filed 2026-07-22 | 4.01M shares derived: average of 2 quarters · filed 2026-07-22 | 3.75M shares derived: average of 3 quarters · filed 2026-07-22 | 3.58M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | 3.81M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | 3.52M shares derived: average of 2 quarters · filed 2026-07-22 | 3.37M shares derived: average of 3 quarters · filed 2026-08-04 | 3.18M shares S-4/A · filed 2026-07-22 | ||||
| 2025-09-30 | 3.23M shares 10-Q · filed 2025-11-12 | 3.15M shares derived: average of 2 quarters · filed 2026-08-04 | 2.97M shares 10-Q · filed 2025-11-12 | 2.85M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | 3.07M shares 10-Q · filed 2026-08-04 | 2.84M shares 10-Q · filed 2026-08-04 | 2.72M shares derived: average of 3 quarters · filed 2026-08-04 | 2.67M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | 2.56M shares S-4/A · filed 2026-07-22 | 2.55M shares derived: average of 2 quarters · filed 2026-07-22 | 2.54M shares derived: average of 3 quarters · filed 2026-07-22 | 2.53M shares derived: average of 4 quarters · filed 2026-07-22 | ||||
| 2024-12-31 | 2.54M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | 2.53M shares derived: average of 2 quarters · filed 2026-07-22 | 2.53M shares derived: average of 3 quarters · filed 2026-07-22 | 2.52M shares S-4/A · filed 2026-07-22 | ||||
| 2024-09-30 | 2.53M shares 10-Q · filed 2025-11-12 | 2.52M shares derived: average of 2 quarters · filed 2025-11-12 | 2.51M shares 10-Q · filed 2025-11-12 | 2.50M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 2.51M shares 10-Q · filed 2025-08-05 | 2.50M shares 10-Q · filed 2025-08-05 | 2.49M shares derived: average of 3 quarters · filed 2025-11-12 | 2.47M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-03-31 | 2.49M shares 10-Q · filed 2025-05-06 | 2.47M shares derived: average of 2 quarters · filed 2025-11-12 | 2.46M shares derived: average of 3 quarters · filed 2025-11-12 | 2.42M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2023-12-31 | 2.46M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | 2.44M shares derived: average of 2 quarters · filed 2025-11-12 | 2.39M shares derived: average of 3 quarters · filed 2025-11-12 | 2.34M shares 10-K/A · filed 2025-11-12 | ||||
| 2023-09-30 | 2.44M shares 10-Q · filed 2024-11-14 | 2.36M shares derived: average of 2 quarters · filed 2024-11-14 | 2.30M shares 10-Q · filed 2024-11-14 | 2.27M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 2.28M shares 10-Q · filed 2024-08-07 | 2.23M shares 10-Q · filed 2024-08-07 | 2.21M shares derived: average of 3 quarters · filed 2024-08-07 | 2.20M shares derived: average of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | 2.18M shares 10-Q · filed 2024-05-07 | 43.52K shares 10-Q · filed 2023-05-12 | 2.17M shares derived: average of 2 quarters · filed 2024-05-07 | 2.17M shares derived: average of 3 quarters · filed 2024-05-07 | 2.17M shares derived: average of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | 2.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 2.17M shares derived: average of 2 quarters · filed 2024-03-05 | 2.17M shares derived: average of 3 quarters · filed 2024-03-05 | 2.17M shares 10-K · filed 2024-03-05 | 43.47M shares 10-K · filed 2023-03-22 | |||
| 2022-09-30 | 2.17M shares 10-Q · filed 2023-11-13 | 43.49M shares 10-Q · filed 2022-11-03 | 2.17M shares derived: average of 2 quarters · filed 2023-11-13 | 2.17M shares 10-Q · filed 2023-11-13 | 43.46M shares 10-Q · filed 2022-11-03 | 11.94M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 2.17M shares 10-Q · filed 2023-07-28 | 43.46M shares 10-Q · filed 2022-08-09 | 2.17M shares 10-Q · filed 2023-07-28 | 43.44M shares 10-Q · filed 2022-08-09 | 15.20M shares derived: average of 3 quarters · filed 2023-07-28 | 22.22M shares derived: average of 4 quarters · filed 2023-07-28 | ||
| 2022-03-31 | 43.42K shares 10-Q · filed 2023-05-12 | 21.71M shares derived: average of 2 quarters · filed 2023-05-12 | 28.91M shares derived: average of 3 quarters · filed 2023-05-12 | 30.61M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 43.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 43.34M shares derived: average of 2 quarters · filed 2023-03-22 | 40.79M shares derived: average of 3 quarters · filed 2023-03-22 | 39.14M shares 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 43.29M shares 10-Q · filed 2022-11-03 | 39.50M shares derived: average of 2 quarters · filed 2022-11-03 | 37.73M shares 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | 35.71M shares 10-Q · filed 2022-08-09 | 34.90M shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |